YAP transcriptionally regulates ErbB2 to promote liver cell proliferation

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · see citing works

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · see citing works

Global cancer statistics, 2012

Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,858 · see citing works

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · see citing works

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 11,930 · see citing works

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ <i>neu</i> Oncogene

Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · see citing works

The Human Genome Browser at UCSC

Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400 · see citing works

MYC on the Path to Cancer

Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390 · see citing works

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes &amp; Development · doi:10.1101/gad.1602907 · Cited by 3,092 · see citing works

Mapping and analysis of chromatin state dynamics in nine human cell types

Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898 · see citing works

Elucidation of a universal size-control mechanism in Drosophila and mammals

Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370 · see citing works

The Hippo Signaling Pathway in Development and Cancer

Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,274 · see citing works

YAP/TAZ at the Roots of Cancer

Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970 · see citing works

The Biology of YAP/TAZ: Hippo Signaling and Beyond

Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,797 · see citing works

Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling

Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628 · see citing works

ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

Graus-Porta, D., Beerli, R. R., Daly, J. M., & Hynes, N. E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1647 · Cited by 1,593 · see citing works

Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes &amp; Development · doi:10.1101/gad.192856.112 · Cited by 1,452 · see citing works

YAP1 increases organ size and expands undifferentiated progenitor cells

Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252 · see citing works

The emerging roles of YAP and TAZ in cancer

Moroishi, T., Hansen, C. G., & Guan, K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3876 · Cited by 1,156 · see citing works

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065 · see citing works

Hippo signaling: growth control and beyond

Halder, G. A., & Johnson, R. L. (2010) · Development · doi:10.1242/dev.045500 · Cited by 1,061 · see citing works

A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor

Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., & Yarden, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5276 · Cited by 1,039 · see citing works

ErbB receptors and signaling pathways in cancer

Hynes, N. E., & MacDonald, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.010 · Cited by 956 · see citing works

Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

Zhou, D., Conrad, C. H., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W. E., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 916 · see citing works

Hippo Pathway Activity Influences Liver Cell Fate

Yimlamai, D., Christodoulou, C., Galli, G. G., Yanger, K., Pepe-Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B. Z., & Camargo, F. D. (2014) · Cell · doi:10.1016/j.cell.2014.03.060 · Cited by 857 · see citing works

The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals

Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804 · see citing works

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G. A., Finegold, M. J., Lee, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911427107 · Cited by 721 · see citing works

Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma

Chiang, D. Y., Villanueva, A., Hoshida, Y., Peix, J., Newell, P., Minguez, B., LeBlanc, A. C., Donovan, D. J., Thung, S. N., Solé, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0742 · Cited by 719 · see citing works

The E2F transcriptional network: old acquaintances with new faces

Dimova, D. K., & Dyson, N. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208612 · Cited by 715 · see citing works

Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression

Song, H., Mak, K. K., Topol, L. Z., Yun, K., Hu, J., Garrett, L. J., Chen, Y., Park, O., Chang, J., Simpson, R. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911409107 · Cited by 583 · see citing works

The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis

Lee, K., Lee, J., Kim, T., Kim, T., Park, H.-D., Byun, J., Kim, M., Jeong, W., Calvisi, D. F., Kim, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912203107 · Cited by 494 · see citing works

YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway

Zhang, J., Ji, J., Yu, M., Overholtzer, M., Smolen, G. A., Wang, R., Brugge, J. S., Dyson, N. J., & Haber, D. A. (2009) · Nature Cell Biology · doi:10.1038/ncb1993 · Cited by 427 · see citing works

Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations

Kreamer, B. L., Staecker, J. L., Sawada, N., Sattler, G. L., Hsia, M. T. S., & Pitot, H. C. (1986) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02623304 · Cited by 383 · see citing works

Distinct Properties of Cell-Type-Specific and Shared Transcription Factor Binding Sites

Gertz, J., Savic, D., Varley, K. E., Partridge, E. C., Safi, A., Jain, P., Cooper, G. M., Reddy, T. E., Crawford, G. E., & Myers, R. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.037 · Cited by 363 · see citing works

Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1

Fan, R., Kim, N., & Gumbiner, B. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216462110 · Cited by 339 · see citing works

Regulation of the Hippo Pathway Transcription Factor TEAD

Lin, K. C., Park, H. W., & Guan, K. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.09.003 · Cited by 334 · see citing works

The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer

Song, S., Honjo, S., Jin, J., Chang, S.-S., Scott, A. W., Chen, Q., Kalhor, N., Correa, A. M., Hofstetter, W. L., Albarracin, C. T., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2191 · Cited by 274 · see citing works

Nf2 /Merlin controls progenitor homeostasis and tumorigenesis in the liverPreprint

Benhamouche, S., Curto, M., Saotome, I., Gladden, A. B., Liu, C.-H., Giovannini, M., & McClatchey, A. I. (2010) · Genes & Development · doi:10.1101/gad.1938710 · Cited by 269 · see citing works

The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.

Bosher, J. M., Williams, T., & Hurst, H. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.744 · Cited by 229 · see citing works

LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development

Lee, D.-H., Park, J. O., Kim, T.-S., Kim, S.-K., Kim, T.-H., Kim, M.-C., Park, G. S., Kim, J.-H., Kuninaka, S., Olson, E. N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11961 · Cited by 196 · see citing works

Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration

Lu, L., Finegold, M. J., & Johnson, R. L. (2018) · Experimental &amp; Molecular Medicine · doi:10.1038/emm.2017.205 · Cited by 190 · see citing works

Hepatitis B virus X protein modulates oncogene yes-associated protein by CREB to promote growth of hepatoma cells

Zhang, T., Zhang, J., You, X., Liu, Q., Du, Y., Gao, Y., Shan, C., Kong, G., Wang, Y., Yang, X. Y., et al. (2012) · Hepatology · doi:10.1002/hep.25899 · Cited by 182 · see citing works

Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2

Wu, J., Lee, C., Yokom, D. W., Jiang, H., Cheang, M. C. U., Yorida, E., Turbin, D. A., Berquin, I. M., Mertens, P. R., Iftner, T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3561 · Cited by 159 · see citing works

Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing

Wederell, E. D., Bilenky, M., Cullum, R., Thiessen, N., Dagpinar, M., Delaney, A., Varhol, R., Zhao, Y., Zeng, T., Bernier, B., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn382 · Cited by 150 · see citing works

The role of EGF ‐ EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment

Huang, P., Xu, X., Wang, L., Zhu, B., Wang, X., & Xia, J. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12153 · Cited by 123 · see citing works

Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver

Hoffman, B. G., Robertson, G., Zavaglia, B., Beach, M., Cullum, R., Lee, S., Soukhatcheva, G., Li, L., Wederell, E. D., Thiessen, N., et al. (2010) · Genome Research · doi:10.1101/gr.104356.109 · Cited by 115 · see citing works

YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression

He, C., Lv, X., Hua, G., Lele, S. M., Remmenga, S. W., Dong, J., Davis, J. S., & Wang, C. (2015) · Oncogene · doi:10.1038/onc.2015.52 · Cited by 114 · see citing works

Hippo Signaling Influences HNF4A and FOXA2 Enhancer Switching during Hepatocyte Differentiation

Alder, O., Cullum, R., Lee, S., Kan, A. C., Wei, W., Yi, Y., Garside, V. C., Bilenky, M., Griffith, M., Morrissy, A. S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.046 · Cited by 113 · see citing works

Diverse expression of ErbB receptor proteins during rat liver development and regeneration

Carver, R. S., Stevenson, M. C., Scheving, L. A., & Russell, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37060 · Cited by 111 · see citing works

Ets regulation of the erbB2 promoter

Scott, G. K., Chang, C.-H., Erny-Albrecht, K. M., Xu, F., Fredericks, W. J., Rauscher, F. J., Thor, A. D., & Benz, C. C. (2000) · Oncogene · doi:10.1038/sj.onc.1204041 · Cited by 76 · see citing works

Yes‐associated protein/TEA domain family member and hepatocyte nuclear factor 4‐alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice

Cai, W., Lin, L., Hao, H., Zhang, S., Ma, F., Hong, X., Zhang, H., Liu, Q., Ye, G., Sun, G., et al. (2016) · Hepatology · doi:10.1002/hep.28911 · Cited by 76 · see citing works

YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor–Induced Activation of the PI3K Pathway

Wang, C., Gu, C., Jeong, K. J., Zhang, D., Guo, W., Lu, Y., Ju, Z., Panupinthu, N., Yang, J. Y., Gagea, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-15-3084 · Cited by 58 · see citing works

Increased expression of ErbB‐2 in liver is associated with hepatitis B × antigen and shorter survival in patients with liver cancer

Liu, J., Ahiekpor, A., Li, L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24580 · Cited by 43 · see citing works

Yes-associated protein in the liver: Regulation of hepatic development, repair, cell fate determination and tumorigenesis

Nguyen, Q. P., Anders, R. A., Alpini, G. D., & Bai, H. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.05.011 · Cited by 29 · see citing works

A new cis element is involved in the HER2 gene overexpression in human breast cancer cells.

Grooteclaes, M., Vernimmen, D., Plaza, S., Pasleau, F., Hodzic, D. M., & Winkler-Gol, R. (1999) · PubMed · Cited by 28 · see citing works

Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2overexpression in breast cancer cell lines

Nolens, G., Pignon, J., Koopmansch, B., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2450 · Cited by 28 · see citing works

Hepatitis B virus X protein mediates yes-associated protein 1 upregulation in hepatocellular carcinoma

Wu, Y., Zhang, J., Zhang, H., & Zhai, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4885 · Cited by 24 · see citing works

IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism

Cui, J., Tian, J., Wang, W., He, T., Li, X., Gu, C., Wang, L., Wu, J., & Shang, A. (2021) · Cancer Science · doi:10.1111/cas.15083 · Cited by 90 · see citing works

The hippo pathway: A master regulator of liver metabolism, regeneration, and disease

Nguyen‐Lefebvre, A. T., Selzner, N., Wrana, J. L., & Bhat, M. (2021) · The FASEB Journal · doi:10.1096/fj.202002284rr · Cited by 58 · see citing works

Brahma Related Gene 1 (Brg1) Regulates Cellular Cholesterol Synthesis by Acting as a Co-factor for SREBP2

Fan, Z., Kong, M., Li, M., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00259 · Cited by 40 · see citing works

Targeting YAP suppresses ovarian cancer progression through regulation of the PI3K/Akt/mTOR pathway

Xiao, W., Jia, Y., Lou, H., et al. (2019) · Oncology Reports · doi:10.3892/or.2019.7370 · Cited by 28 · see citing works

Phytochemical Analysis Using UPLC-MSn Combined with Network Pharmacology Approaches to Explore the Biomarkers for the Quality Control of the Anticancer Tannin Fraction of Phyllanthus emblica L. Habitat in Nepal

Wu, L., Zhang, Q., Liang, W., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6623791 · Cited by 25 · see citing works

Signalling pathways and transcriptional regulators orchestrating liver development and cancer

Campbell, S. A., Stephan, T. L., Lotto, J., Cullum, R., Drissler, S., & Hoodless, P. A. (2021) · Development · doi:10.1242/dev.199814 · Cited by 22 · see citing works

Pan-cancer analysis, cell and animal experiments revealing TEAD4 as a tumor promoter in ccRCC

Li, F., Feng, Y., Jiang, Q., Zhang, J., Wu, F., Li, Q., Jing, X., Wang, X., & Huang, C. Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120327 · Cited by 23 · see citing works

Verteporfin attenuates trauma‐induced heterotopic ossification of Achilles tendon by inhibiting osteogenesis and angiogenesis involving YAP /β‐catenin signaling

Luo, G., Sun, Z., Liu, H., Yuan, Z., Wang, W., Tu, B., Li, J., & Fan, C. (2023) · The FASEB Journal · doi:10.1096/fj.202300568r · Cited by 20 · see citing works

Mechano-Signaling Aspects of Hepatocellular Carcinoma

Passi, M., & Stefan Zahler, A. (2021) · Journal of Cancer · doi:10.7150/jca.60102 · Cited by 19 · see citing works

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway

Mranda, G. M., Xiang, Z., Liu, J., Tian, W., & Ding, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.937957 · Cited by 17 · see citing works

Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram

Zhang, G., Wang, Y., Fuchs, B. C., Guo, W., Drum, D. L., Erstad, D. J., Shi, B., DeLeo, A. B., Zheng, H. W., Cai, L., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.913736 · Cited by 16 · see citing works

Uncovering the Mechanism of the Effects of Pien-Tze-Huang on Liver Cancer Using Network Pharmacology and Molecular Docking

Liu, S., Wang, R., Lou, Y., et al. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/4863015 · Cited by 16 · see citing works

MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the Optic atrophy 3 promoter and activating its expression

Liu, M., Du, Q., Mao, G., Dai, N., & Zhang, F. (2022) · Bioengineered · doi:10.1080/21655979.2021.2017630 · Cited by 16 · see citing works

TEAD4: A key regulator of tumor metastasis and chemoresistance - Mechanisms and therapeutic implications

Liu, M., Hu, W., Meng, X., & Wang, B. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189050 · Cited by 13 · see citing works

Expression profiling and functional characterization of the duplicated Oxr1b gene in zebrafish

Xu, H., Guo, W., Chi, Y.-Y., Kou, Y.-X., & Li, Y. (2021) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2021.100857 · Cited by 7 · see citing works

GSTT1 as a Predictive Marker and Enhancer for Osteogenic Potential of Human Adipose-Derived Stromal/Stem Cells

Lee, E., Moon, J.-Y., Ko, J., Park, S., & Im, G. (2023) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4893 · Cited by 5 · see citing works

Research progress in role of Hippo signaling pathway in diagnosis and treatment for hepatocellular carcinoma.

Ma, J., & Huang, X. (2021) · PubMed · doi:10.11817/j.issn.1672-7347.2021.200243 · Cited by 4 · see citing works

Roles of TEAD Transcription Factors and their Coactivators in the Progression and Metastasis of Cancers

Li, X. F., Zhang, N., Li, P.-Q., Chu, H.-Q., Zhao, D. H., Qin, W. D., Gong, S., & Cao, H. (2025) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/0115748928383622250729144741 · Cited by 1 · see citing works

YAP/TAZ-mediated resistance to EGFR inhibitors

Yamaguchi, H., & Taouk, G. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822833-3.00004-8 · Cited by 1 · see citing works

AMF30a promotes survival and function of human corneal endothelial cells by regulating TGF-β/ROCK/HIPPO pathway

Ryu, Y., Son, H.-J., Hwang, J. S., Noh, K. B., Oh, S., Choi, E., & Shin, Y. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-13656-2 · Cited by 1 · see citing works

TEAD4 Induced Positive Feedback Activation of E2R/YAP1 Axis and Promoted Epithelial-mesenchymal Transition through Up-regulating TWIST1 Directly in HCCPreprint

Liu, L., Ke, M., Shang, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-602611/v1

New Insights into the Roles of the Hippo Signaling Pathway in Stem Cell Biology

Nilchi, A. N., Dehghanian, F., Khalilian, S., & Imani, S. Z. H. (2023) · Jentashapir Journal of Cellular and Molecular Biology · doi:10.5812/jjcmb-136938 · Cited by 1 · see citing works

Radix Scrophulariae regulates proliferation, apoptosis, and autophagy of rat thyroid cells via the MST1/Hippo signaling pathway

Zhang, N., Xu, L. U., He, J.-X., & Ye, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-20072-z

Mechanical unloading promotes adult cardiomyocyte proliferation through epicardial NRG1–ERBB4 signaling

Jiang, C., Liu, T., Dai, Z., et al. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00841-3

The mammalian Hippo pathway: regulation and function of YAP1 and TAZ

Kodaka, M., & Hata, Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1742-9 · Cited by 108 · see citing works

Molecular Mechanism of Hippo–YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration

Chen, X., Li, Y., Luo, J., & Hou, N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00389 · Cited by 74 · see citing works

Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling

Ota, M., & Sasaki, H. (2008) · Journal of Cell Science · Cited by 7 · see citing works

High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer

Kim, E., Ahn, B., Oh, H., et al. (2019) · Pathology · doi:10.1016/j.pathol.2019.01.001 · Cited by 23 · see citing works

The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway

Wang, M., Dai, M., Wang, D., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.025 · Cited by 38 · see citing works